Sterling Pharma Solutions

Sterling Pharma Solutions, established in 2015, operates as a Contract Development and Manufacturing Organisation (CDMO) focused on API and ADC services for the pharmaceutical and biotech sectors. With a legacy spanning over 50 years, the company provides comprehensive support throughout the molecule lifecycle, from initial discovery phases to full commercial manufacturing. Its strategically located facilities in the UK and the US are specifically equipped to manage complex processes, including high potency APIs, hazardous chemistry, and advanced peptide manufacturing, ensuring a broad spectrum of service capabilities.

The organization places a strong emphasis on scientific collaboration and continuous innovation, aiming to deliver efficient and cost-effective routes to market for its clients' therapeutic candidates. Sterling Pharma Solutions' dedication to scientific excellence and stringent quality standards is fundamental to its approach in managing projects from preclinical development through to large-scale GMP production. The expertise of its personnel is a critical factor in navigating the intricate landscape of drug development and manufacturing. Meet Sterling Pharma Solutions's team to gain insight into their specialized knowledge and operational capacity.

Within the competitive pharmaceutical and healthcare industries, Sterling Pharma Solutions leverages its specialized capabilities to serve a global clientele. Its strategic focus on complex chemistry and high-value manufacturing solutions positions it as a key partner for companies requiring reliable supply chain support. The company's revenue of $455.7M and an employee range of 1,000-5,000 employees signify substantial operational scale and capacity. With 5 distinct locations, Sterling Pharma Solutions maintains a significant geographic presence to address diverse client needs.